Thanks to @MedTechAwards for inviting CEO @JoeMuldoon2 to be a part of the MTI Asia Pacific webinar as a panelist discussing how to best attract talent and build effective advisory boards. Get a full recap here: bit.ly/2022APLive3

Dr. Tariq Shafi, Chair of Nephrology @UMMCnews @UMMCMedicine, publishes research that shows estimated GFR is not an absolute or direct measure of kidney function: umc.edu/news/News_Articles/2… @DrTariqShafi

We were recently awarded a patent for our method and apparatus for determining biometric indicators using multiple fluorescent markers by the @EPOorg. This patent is validated in France, Germany and Great Britain.

FAST BioMedical will be attending the Wilson Sonsini Medical Device Conference June 16-17 in San Francisco! We are looking forward connecting with our #medtech peers and attending a full day of panel discussions.

Honored to be 1 of 3 #medtech companies in the Emerging Technologies in Heart Failure panel at this year’s @BankofAmerica Securities 2022 Healthcare conference earlier this month. Here are some highlights from @JoeMuldoon2’s presentation.

A huge thank you to @escardio for allowing us to present at last weekend's #HeartFailure2022 in Madrid! CEO @JoeMuldoon2 recapped the event saying, "We are overwhelmed by the positive response to our presentation. We have many new potential clinical collaborators!"

We’re looking forward to @escardio’s World Congress on Acute Heart Failure this weekend in Madrid! CEO @JoeMuldoon2 will be presenting on May 22 as part of the “Rapid parade of devices: emerging treatment options in heart failure” panel. #HeartFailure2022 digital-congress.escardio.or…

We’re proud to celebrate #NurseAppreciationWeek and are grateful to have @HFSA’s first nurse President, Dr. Nancy Albert, RN, PhD, FHFSA, as a member of our Heart Failure Medical Advisory Board.

We’re in beautiful Dublin, Ireland, this week for the @MedTechStrat Innovation Summit. Stay tuned to hear about our experience directly from CEO @JoeMuldoon2!

CEO @JoeMuldoon2 is wrapping up the third and final day of @MedTechStrat #InnovationDublin22. Hear how things went and wish him a safe journey home! ✈️

By leveraging nurses’ insights & connecting with patient advocacy groups & medical societies, medtech companies can better incorporate patients’ voices during the clinical trial process & beyond. Read CEO @JoeMuldoon2’s interview with @TrialsArena. clinicaltrialsarena.com/anal…

CEO @joemuldoon2 was quoted in @MedicalTechMag speaking on the importance of incorporating patients’ voices during the clinical trial process and beyond by connecting with patient advocacy groups and medical societies, and leveraging insight from nurses. medical-technology.nridigita…

During Day 3 of #LSIUSA22, @joemuldoon2 reports good weather, great content and even better connections! 😎

It was fun to reconnect with our ecosystem at last week's LSI Emerging Medtech Summit. Pictured below is only a fraction of the nearly 100 alumni and partners that were at the conference. #medtech

In January, the FDA released new guidance for involving patients in medical device trials. CEO @joemuldoon2 spoke with @TrialsArena about the importance for any medical technology to incorporate patients’ voices during the clinical trial process & beyond. clinicaltrialsarena.com/anal…

Ladies and gentlemen, Bill Murray. 🙈

Our CEO @joemuldoon2 sat down with Chris LaMothe, CEO of @ElevateIN, to discuss what Elevate looks for in potential investments. Watch Part 1 of their conversation below! #FBMCEOChats

As a part of our ongoing Heart Failure series, CEO @joemuldoon2 recently sat down with Frank Peacock, MD, FACEP, FACC, a member of our Heart Failure Medical Advisory Board, for a Q&A on the potential for FAST’s technology to revolutionize the treatment for #heartfailure patients.